Blueprint Medicines' Q1 Earnings Decline, Revenue Increases-March 2024-www.financetom.com

Blueprint Medicines' Q1 Earnings Decline, Revenue Increases

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Blueprint Medicines' Q1 Earnings Decline, Revenue Increases

May 25, 2025 11:21 PM

09:40 AM EDT, 05/01/2025 (MT Newswires) -- Blueprint Medicines ( BPMC ) reported Q1 earnings Thursday of $0.01 per diluted share, down from $1.40 a year earlier.

Analysts polled by FactSet expected a loss of $0.49 per share.

Revenue for the quarter ended March 31 was $149.4 million, compared with $96.1 million a year earlier.

Analysts surveyed by FactSet expected $155.5 million.

Price: 91.33, Change: +1.83, Percent Change: +2.04

Previous page： Mattr Q3 Profit Falls on Higher Costs Despite 39% Revenue Growth Next page： Enova Approves $400 Million Share Repurchase Program

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Mattr Q3 Profit Falls on Higher Costs Despite 39% Revenue Growth

Nov 12, 2025

05:33 PM EST, 11/12/2025 (MT Newswires) -- Mattr ( MTTRF ) on Wednesday reported a lower third-quarter profit despite higher revenue, driven by solid performance across its core business segments. Net income for the period dropped to $2.9 million, or $0.04 per share, from $12.8 million, or $0.19, a year earlier. Revenue from continuing operations grew 39% to $315 million...

Enova Approves $400 Million Share Repurchase Program

Nov 12, 2025

05:33 PM EST, 11/12/2025 (MT Newswires) -- Enova International ( ENVA ) said late Wednesday its board approved a new $400 million share repurchase program, set to expire on June 30, 2027. The new program replaces the company's existing $300 million buyback plan, which was scheduled to expire on Dec. 31, according to a statement. ...

Quantumscape Insider Sold Shares Worth $329,441, According to a Recent SEC Filing

Nov 12, 2025

05:30 PM EST, 11/12/2025 (MT Newswires) -- Michael O McCarthy III, Chief Legal Officer, on November 07, 2025, sold 20,435 shares in Quantumscape ( QS ) for $329,441. Following the Form 4 filing with the SEC, McCarthy has control over a total of 137,888 Class A common shares of the company, with 137,888 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1811414/000117726425000016/xslF345X05/primarydocument.xml ...

Banco do Brasil cuts 2025 net income outlook as farmer defaults surge

Nov 12, 2025

SAO PAULO (Reuters) -Brazilian state-run lender Banco do Brasil on Wednesday lowered its outlook for adjusted net income this year, citing higher funding expenses and rising defaults among local farmers. The bank now expects annual net income of 18 billion to 21 billion reais ($3.33 billion-$3.89 billion), down from a previous forecast of 21-25 billion reais. Banco do Brasil, long...